NCT04579848View on ClinicalTrials.gov

Methotrexate in Erosive Inflammatory Hand Osteoarthritis

PHASE4RecruitingINTERVENTIONAL
Enrollment

163

Participants

Timeline

Start Date

August 12, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Hand OsteoarthritisErosive Osteoarthritis
Interventions
DRUG

Methotrexate Tablets

Methotrexate 2.5mg oral tablet.

DRUG

Placebo

Placebo capsule

DRUG

Folic Acid 1 MG

Folic acid

Trial Locations (1)

Unknown

RECRUITING

Diakonhjemmet Hospital, Oslo

All Listed Sponsors
collaborator

Oslo University Hospital

OTHER

lead

Diakonhjemmet Hospital

OTHER